Search results
$13.21 billion
- The attention deficit hyperactivity disorder (ADHD) therapeutics market size has grown strongly in recent years. It will grow from $12.37 billion in 2023 to $13.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%.
www.researchandmarkets.com › reports › 5953399Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics ...
People also ask
What is the value of the ADHD therapeutics market in 2024?
Why is the global ADHD therapeutics market growing?
What is the outlook for the ADHD therapeutics market?
The global ADHD therapeutics market is anticipated to reach USD 54.34 billion by 2029 from USD 35.17 billion in 2024, growing at a CAGR of 9.09% during the forecast period. Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that damages and envelops symptoms of impulsivity and hyperactivity.
Dec 10, 2023 · The global ADHD therapeutics market is estimated at a value of US$ 25.05 billion in 2024. Revenue from ADHD therapeutics is predicted to rise at a CAGR of 6.2% from 2024 to 2034. The market...
ADHD Therapeutics Industry compound annual growth rate (CAGR) will be XX% from 2024 till 2031." ADHD Therapeutics Market Size, CAGR and Industry Statistics. Cognitive Market Research has recently published the 7th edition of ADHD Therapeutics Market Report 2024. It provides majorly two types of information qualitative and quantitative.
- (6)
May 5, 2024 · The main findings of the report suggest that the global ADHD Therapeutics market is expected to reach a value of $25 billion by 2024, with a CAGR of %.
The global attention deficit hyperactivity disorder market size was estimated at USD 14.3 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2030.
- Based on drug type, the stimulant segment accounted for a share of 71.91% in 2022 due to high prescription and usage rate of stimulant drugs due to...
- Some of the key players in the attention deficit hyperactivity disorder market are Novartis AG, Eli Lilly and Company, Johnson & Johnson Services,...
- The major factors driving the market growth are the increasing prevalence of ADHD and increasing awareness about ADHD among physicians and patients...
Apr 16, 2024 · The attention deficit hyperactivity disorder (ADHD) therapeutics market has demonstrated robust growth, advancing from $12.37 billion in 2023 to $13.21 billion in 2024, registering a compound annual growth rate (CAGR) of 6.8%.
It will grow from $12.37 billion in 2023 to $13.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%.
